VxP Biologics provides extensive mammalian, microbial, and antiviral pharmaceutical R&D service offerings to support the preclinical and clinical development of your biologics and biosimilars.

Services include:

  • Cell line development
  • Microbial strain development
  • Vaccine Design & Development
  • Customized protein expression systems
  • Cell bank production
  • Process development/Optimization
  • Technology transfer
  • Model development & Process characterization

Each customer project is customized to match the required scope and clinical phase. Commercial and in-house mammalian, microbial, and antiviral platform processes enable efficient movement through development programs and into commercialization.

Our Analytical Department is completely integrated with our R&D services to provide a consistent evaluation of your product throughout the entire development path. Our development team is also experienced with quick and efficient technology transfer to establish a variety of proven cell culture and microbial fermentation processes. We will ensure that you receive a seamless route from R&D to clinical scale-up and cGMP manufacturing.

Contact us today for a free consultation about your Biologics program today.